KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $2.1 billion.

  • Cvs Health's Short-term Investments fell 1088.49% to $2.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.1 billion, marking a year-over-year decrease of 1088.49%. This contributed to the annual value of $2.1 billion for FY2025, which is 1088.49% down from last year.
  • Latest data reveals that Cvs Health reported Short-term Investments of $2.1 billion as of Q4 2025, which was down 1088.49% from $2.1 billion recorded in Q3 2025.
  • In the past 5 years, Cvs Health's Short-term Investments registered a high of $3.8 billion during Q2 2024, and its lowest value of $2.1 billion during Q3 2025.
  • Its 5-year average for Short-term Investments is $2.9 billion, with a median of $3.0 billion in 2021.
  • Its Short-term Investments has fluctuated over the past 5 years, first soared by 2191.56% in 2024, then crashed by 3645.81% in 2025.
  • Cvs Health's Short-term Investments (Quarter) stood at $3.1 billion in 2021, then fell by 10.88% to $2.8 billion in 2022, then increased by 17.31% to $3.3 billion in 2023, then fell by 26.14% to $2.4 billion in 2024, then fell by 10.88% to $2.1 billion in 2025.
  • Its last three reported values are $2.1 billion in Q4 2025, $2.1 billion for Q3 2025, and $2.4 billion during Q2 2025.